PE20081388A1 - Derivados de amina como agonistas del adrenoreceptor b2 - Google Patents
Derivados de amina como agonistas del adrenoreceptor b2Info
- Publication number
- PE20081388A1 PE20081388A1 PE2008000006A PE2008000006A PE20081388A1 PE 20081388 A1 PE20081388 A1 PE 20081388A1 PE 2008000006 A PE2008000006 A PE 2008000006A PE 2008000006 A PE2008000006 A PE 2008000006A PE 20081388 A1 PE20081388 A1 PE 20081388A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- ethyl
- halogen
- compounds
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE AMINA DE FORMULA (I) DONDE Ar ES UN COMPUESTO DE FORMULA (i), (ii), ENTRE OTROS, EN DONDE R43 Y R44 SON CADA UNO H, HALOGENO, TRIFLUOROMETILO, CN, ENTRE OTROS; R2, R3, R4, R5, R4' Y R5' SON CADA UNO H O ALQUILO(C1-C6); A ES CH2, C(O) O S(O)2; D ES O, S O NR8, DONDE R8 ES H O ALQUILO(C1-C6); E ES UN ENLACE, CR63R64, ENTRE OTROS, DONDE R63 Y R64 SON CADA UNO H, ALQUILO(C1-C4) O F; k ES 0 O 1; m ES DE 0 A 3; R6 ES -(X)p-Y-(Z)q-R10 O ALQUILO(C3-C12) OPCIONALMENTE SUSTITUIDO CON HALOGENO, ALCOXI(C1-C6), ALQUILTIO(C1-C6), ENTRE OTROS, EN DONDE X Y Z SON CADA UNO ALQUILENO(C1-C6), ENTRE OTROS; p Y q SON CADA UNO 0 O 1; Y ES UN ENLACE, O, S, CH2, C(O), ENTRE OTROS; R10 ES H O UN SISTEMA DE ANILLOS DE 3 A 12 MIEMBROS; R7 ES UN SISTEMA DE ANILLOS AROMATICO O HETEROAROMATICO DE 5 A 14 MIEMBROS SUSTITUIDO OPCIONALMENTE CON HALOGENO, TRIFLUOROMETILO, OH, CARBOXILO, ALQUILO(C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-BUTIL-N-(2-(2-(8-HIDROXI-2-OXO-1,2-DIHIDROQUINOLIN-5-IL)ETILAMINO)ETIL)-3-FENETOXIPROPANAMIDA, N-CICLOHEXIL-N-(2-(3-FORMAMIDO-4-HIDROXIFENETILAMINO)ETIL)-3-(FENETILAMINO)PROPANAMIDA, N-CICLOHEXIL-N-[2-({2-[4-HIDROXI-3-(HIDROXIMETIL)FENIL]ETIL}AMINO)ETIL]-N3-(2-FENILETIL)- -ALANINAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON AGONISTAS DEL ADRENORECEPTOR 2 SIENDO UTILES EN EL TRATAMIENTO DE ENFISEMA PULMONAR, BRONQUITIS, ASMA, RINITIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87095606P | 2006-12-20 | 2006-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20081388A1 true PE20081388A1 (es) | 2008-11-26 |
Family
ID=39048968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008000006A PE20081388A1 (es) | 2006-12-20 | 2008-01-02 | Derivados de amina como agonistas del adrenoreceptor b2 |
Country Status (19)
Country | Link |
---|---|
US (2) | US20120142646A1 (es) |
EP (1) | EP2094646A1 (es) |
JP (1) | JP2010513439A (es) |
KR (1) | KR20090094149A (es) |
CN (1) | CN101636379A (es) |
AR (1) | AR064636A1 (es) |
AU (1) | AU2007336074B2 (es) |
BR (1) | BRPI0722095A2 (es) |
CA (1) | CA2672792A1 (es) |
CL (1) | CL2007003754A1 (es) |
CO (1) | CO6210822A2 (es) |
EC (1) | ECSP099425A (es) |
MX (1) | MX2009006010A (es) |
NO (1) | NO20092690L (es) |
PE (1) | PE20081388A1 (es) |
RU (1) | RU2472783C2 (es) |
TW (1) | TW200835686A (es) |
UY (1) | UY30811A1 (es) |
WO (1) | WO2008075025A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
NZ586872A (en) | 2008-02-06 | 2012-03-30 | Astrazeneca Ab | Spirocyclic amide compounds |
EP2303873A4 (en) | 2008-06-18 | 2012-01-04 | Astrazeneca Ab | BENZOXAZINE DERIVATIVES AS A BETA2 ADRENORE RECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISEASES |
KR20110022611A (ko) * | 2008-06-20 | 2011-03-07 | 아스트라제네카 아베 | 베타2-아드레날린수용체 활성의 조절을 위한, 4-히드록시-2-옥소-2,3-디히드로-1,3-벤조티아졸-7-일 화합물을 포함하는 제약 조성물 |
GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
WO2011048409A1 (en) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
US9598381B2 (en) * | 2014-07-31 | 2017-03-21 | Abbvie Inc. | SMYD2 inhibitors |
CN107188865B (zh) * | 2016-03-14 | 2019-08-27 | 益方生物科技(上海)有限公司 | 苯并噁嗪化合物及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653977A (en) * | 1953-09-29 | Chxnx | ||
DE3476196D1 (en) * | 1983-01-21 | 1989-02-23 | Fisons Plc | Aromatic amines |
US5648370A (en) * | 1990-11-20 | 1997-07-15 | Astra Pharmaceuticals Limited | 7-(2-aminoethyl) benzothiazolones |
GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
GB0217225D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
TW200745084A (en) * | 2006-03-08 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
-
2007
- 2007-12-19 CA CA002672792A patent/CA2672792A1/en not_active Abandoned
- 2007-12-19 KR KR1020097015072A patent/KR20090094149A/ko not_active Application Discontinuation
- 2007-12-19 BR BRPI0722095-2A2A patent/BRPI0722095A2/pt not_active IP Right Cessation
- 2007-12-19 CN CN200780051580A patent/CN101636379A/zh active Pending
- 2007-12-19 RU RU2009119912/04A patent/RU2472783C2/ru not_active IP Right Cessation
- 2007-12-19 US US11/959,735 patent/US20120142646A1/en not_active Abandoned
- 2007-12-19 JP JP2009542201A patent/JP2010513439A/ja not_active Withdrawn
- 2007-12-19 US US12/519,591 patent/US20100056508A1/en not_active Abandoned
- 2007-12-19 MX MX2009006010A patent/MX2009006010A/es active IP Right Grant
- 2007-12-19 UY UY30811A patent/UY30811A1/es unknown
- 2007-12-19 TW TW096148621A patent/TW200835686A/zh unknown
- 2007-12-19 WO PCT/GB2007/004859 patent/WO2008075025A1/en active Application Filing
- 2007-12-19 EP EP07848596A patent/EP2094646A1/en not_active Withdrawn
- 2007-12-19 AU AU2007336074A patent/AU2007336074B2/en not_active Ceased
- 2007-12-20 CL CL200703754A patent/CL2007003754A1/es unknown
- 2007-12-20 AR ARP070105802A patent/AR064636A1/es not_active Application Discontinuation
-
2008
- 2008-01-02 PE PE2008000006A patent/PE20081388A1/es not_active Application Discontinuation
-
2009
- 2009-05-27 CO CO09054436A patent/CO6210822A2/es not_active Application Discontinuation
- 2009-06-15 EC EC2009009425A patent/ECSP099425A/es unknown
- 2009-07-15 NO NO20092690A patent/NO20092690L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20120142646A1 (en) | 2012-06-07 |
RU2009119912A (ru) | 2011-01-27 |
AU2007336074A1 (en) | 2008-06-26 |
CL2007003754A1 (es) | 2008-08-22 |
AR064636A1 (es) | 2009-04-15 |
EP2094646A1 (en) | 2009-09-02 |
AU2007336074B2 (en) | 2011-09-22 |
KR20090094149A (ko) | 2009-09-03 |
ECSP099425A (es) | 2009-07-31 |
US20100056508A1 (en) | 2010-03-04 |
JP2010513439A (ja) | 2010-04-30 |
BRPI0722095A2 (pt) | 2014-04-01 |
NO20092690L (no) | 2009-09-03 |
CO6210822A2 (es) | 2010-10-20 |
CA2672792A1 (en) | 2008-06-26 |
UY30811A1 (es) | 2008-07-31 |
CN101636379A (zh) | 2010-01-27 |
WO2008075025A1 (en) | 2008-06-26 |
MX2009006010A (es) | 2009-06-16 |
RU2472783C2 (ru) | 2013-01-20 |
TW200835686A (en) | 2008-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20081388A1 (es) | Derivados de amina como agonistas del adrenoreceptor b2 | |
PE20120062A1 (es) | Derivados de 1-bencil-2-amino-tetralina como inhibidores del transportador de glicina glyt1 | |
AR110051A2 (es) | Pirazolo[3,4-d]pirimidinas útiles para tratar trastornos respiratorios | |
PE20061098A1 (es) | COMPUESTOS IMIDAZO[1,2-a] PIRIDINILO COMO INHIBIDORES DE VEGF-R2 | |
PE20080659A1 (es) | Benzotriazoles como moduladores de quinasas | |
PE20120508A1 (es) | Inhibidores de la replicacion de los virus de la gripe | |
TW200800947A (en) | Trisubstituted amine compound | |
PE20061490A1 (es) | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 | |
PE20091010A1 (es) | Derivados de tetrahidroquinolina | |
PE20130215A1 (es) | Nuevos derivados de ciclohexilamina que tienen actividad como agonistas adrenergicos beta2 y como antagonistas muscarinicos m3 | |
PE20090244A1 (es) | Inhibidores de la proteina activadora de la 5-lipoxigenasa (flap) | |
EA200601852A1 (ru) | Тетрагидрохинолиновые производные и способ их получения | |
PE20091623A1 (es) | DERIVADOS DE 1H-PIRAZOLO[3,4-b]PIRIDINA COMO INHIBIDORES DE RAF QUINASA | |
BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
PE20061297A1 (es) | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c | |
PE20090815A1 (es) | Compuesto de amida | |
PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
PE20070362A1 (es) | COMPUESTOS DERIVADOS DE INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA COMO INHIBIDORES DE TIROSINA QUINASA (QUINASA Syk) | |
PE20060076A1 (es) | Antagonistas del receptor de acetilcolina muscarinico | |
PE20090591A1 (es) | Derivados monoamida como antagonistas del receptor de orexina | |
PE20070069A1 (es) | Piperazin-piperidinas como antagonistas y agonistas del receptor 5-ht1a | |
RS52191B (en) | TETRAHYDROCYCLOPENT (B) INDOLE UNITS AS MODULATORS OF ANDROGENIC RECEPTORS | |
NO20081685L (no) | Fremgangsmate for fremstilling oksazolidin-beskyttelse aminodolforbindelser anvendbare som mellomprodukter for Florfenicol | |
UY30903A1 (es) | Nuevas sformas de sales de n-[2-(dietilamino)etil]-n-(2-{[2-(4-hidorxi-2-oxo-2,3-dihidro-1,3-benzotiazol-7-il)etil]amino}etil)-3-[2-(1-naftil)etoxi]propanamida, composiciones comprendiéndolas, procesos de preparacion y aplicaciones. | |
NO20080325L (no) | Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer samt deres anvendelse innen medisin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |